NCT03716583View on ClinicalTrials.gov

Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 30, 2019

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Radiation DermatitisRadiation Dermatitis AcuteBreast Cancer
Interventions
DRUG

Melatonin

25 mg

DRUG

Dimethyl Sulfoxide

150 mg

DRUG

Placebos

1 g

Trial Locations (1)

2100

Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Dennis Bregner Zetner

OTHER

NCT03716583 - Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer | Biotech Hunter | Biotech Hunter